Equities

China Traditional Chinese Medicine Holdings Co Ltd

China Traditional Chinese Medicine Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)2.17
  • Today's Change-0.09 / -3.98%
  • Shares traded79.67m
  • 1 Year change-40.71%
  • Beta0.7320
Data delayed at least 15 minutes, as of Nov 22 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,9043,6704,141
Total Receivables, Net9,5537,9928,794
Total Inventory5,9596,0405,043
Prepaid expenses134150111
Other current assets, total250115115
Total current assets19,80017,96718,203
Property, plant & equipment, net7,9607,9247,866
Goodwill, net3,4583,4563,492
Intangibles, net5,4865,8756,258
Long term investments88105287
Note receivable - long term------
Other long term assets58108--
Total assets37,06835,63736,389
LIABILITIES
Accounts payable2,7431,8892,093
Accrued expenses1,5911,5182,672
Notes payable/short-term debt000
Current portion long-term debt/capital leases2,9694,5142,171
Other current liabilities, total2,0302,1821,829
Total current liabilities9,33310,1038,765
Total long term debt2,1915292,893
Total debt5,1605,0435,064
Deferred income tax1,1871,6191,680
Minority interest2,7762,7802,942
Other liabilities, total421438391
Total liabilities15,90815,46916,671
SHAREHOLDERS EQUITY
Common stock11,98211,98211,982
Additional paid-in capital------
Retained earnings (accumulated deficit)9,3508,3547,914
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(172)(169)(178)
Total equity21,16020,16819,719
Total liabilities & shareholders' equity37,06835,63736,389
Total common shares outstanding5,0365,0365,036
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.